Essex Woodlands Management, Inc.
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Essex Woodlands Management, Inc. reported 7 stock positions worth $350.4 million. Its top holding was Mimedx (MDXG) at 47.6% of the portfolio, followed by Bioventus Class A (BVS, 44.4%) and Eyepoint (EYPT, 3.5%). Its holdings were unchanged from Q2 2024.
- Most Recent 13F
- Q2 2026
- Location
- THE WOODLANDS, TX
- CIK
- 0001542339
- Portfolio Value
- $350.4M (Q3 2024)
- SEC Filing
- 0001398344-24-020745 ↗ filed Nov 14, 2024
Holdings Value
Holdings 7 stocks · $350.4M
| MDXG Mimedx Group Inc. | 47.56% | 28,195,249 | $166.6M | No change |
| BVS Bioventus Inc. Class A | 44.41% | 13,021,324 | $155.6M | No change |
| EYPT Eyepoint Inc. | 3.54% | 1,551,521 | $12.4M | No change |
| TELA Tela Bio Inc. | 2.97% | 4,110,709 | $10.4M | No change |
| RVNC Revance Therapeutics Inc. | 0.68% | 457,085 | $2.4M | No change |
| MNOV Medicinova Inc. | 0.66% | 1,105,941 | $2.3M | No change |
| VENUS CONCEPT INC | 0.19% | 1,089,190 | $665K | No change |
Portfolio Sells Q2 2024 → Q3 2024
| None this quarter. | |||
Portfolio Buys Q2 2024 → Q3 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $254.2M | BVS, MDXG, EYPT, TELA, MNOV |
| Q1 2026 | 5 | $250.5M | BVS, MDXG, EYPT, TELA, MNOV |
| Q4 2025 | 6 | $318.3M | MDXG, BVS, EYPT, TELA, MNOV |
| Q3 2025 | 6 | $307.1M | MDXG, BVS, EYPT, TELA, MNOV |
| Q2 2025 | 6 | $279.1M | MDXG, BVS, EYPT, TELA, MNOV |
| Q1 2025 | 6 | $346.7M | MDXG, BVS, EYPT, TELA, MNOV |
| Q4 2024 | 7 | $433.2M | MDXG, BVS, TELA, EYPT, MNOV |
| Q3 2024 | 7 | $350.4M | MDXG, BVS, EYPT, TELA, RVNC |
| Q2 2024 | 7 | $306.7M | MDXG, BVS, TELA, EYPT, MNOV |
| Q1 2024 | 7 | $344.8M | MDXG, BVS, EYPT, TELA, RVNC |